Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuanlin Ding

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Archivum Immunologiae Et Therapiae Experimentalis|March 10, 2007
Regulation of autoreactive B cells: checkpoints and activationChuanlin Ding, Jun Yan
Cancer Journal (Sudbury, Mass.)|November 26, 2013
Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancerSabrin Husein Albeituni, Chuanlin Ding, Jun Yan
Blood|August 2, 2008
Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1Chuanlin Ding, Li Wang, Jose Marroquin, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|August 28, 2002
[Functional effects of dendritic cells transfected with Epstein-Barr virus latent membrane protein 2A recombinant adenovirus]Guanyong Peng, Kun Yau, Fangyi Xie, et al.
Cancer Biology & Therapy|December 25, 2008
Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapyMichael Driscoll, Richard Hansen, Chuanlin Ding, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2009
Plasmacytoid dendritic cells regulate autoreactive B cell activation via soluble factors and in a cell-to-cell contact mannerChuanlin Ding, Yihua Cai, Jose Marroquin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 29, 2019
Tumor Microenvironment following Gemcitabine Treatment Favors Differentiation of Immunosuppressive Ly6C<sup>high</sup> Myeloid CellsCaijun Wu, Xiaobin Tan, Xiaoling Hu, et al.
Biophysical Journal|February 12, 2022
Immobile ligands enhance FcγR-TLR2/1 crosstalk by promoting interface overlap of receptor clustersMiao Li, Seonik Lee, Maryam Zahedian, et al.
European Journal of Immunology|July 1, 2006
Toll-like receptor engagement stimulates anti-snRNP autoreactive B cells for activationChuanlin Ding, Li Wang, Hayma Al-Ghawi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2019
Tumor Microenvironment Modulates Immunological Outcomes of Myeloid Cells with mTORC1 DisruptionChuanlin Ding, Xiaomin Sun, Caijun Wu, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Archivum Immunologiae Et Therapiae Experimentalis|March 10, 2007
Regulation of autoreactive B cells: checkpoints and activationChuanlin Ding, Jun Yan
Cancer Journal (Sudbury, Mass.)|November 26, 2013
Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancerSabrin Husein Albeituni, Chuanlin Ding, Jun Yan
Blood|August 2, 2008
Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1Chuanlin Ding, Li Wang, Jose Marroquin, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|August 28, 2002
[Functional effects of dendritic cells transfected with Epstein-Barr virus latent membrane protein 2A recombinant adenovirus]Guanyong Peng, Kun Yau, Fangyi Xie, et al.
Cancer Biology & Therapy|December 25, 2008
Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapyMichael Driscoll, Richard Hansen, Chuanlin Ding, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2009
Plasmacytoid dendritic cells regulate autoreactive B cell activation via soluble factors and in a cell-to-cell contact mannerChuanlin Ding, Yihua Cai, Jose Marroquin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 29, 2019
Tumor Microenvironment following Gemcitabine Treatment Favors Differentiation of Immunosuppressive Ly6C<sup>high</sup> Myeloid CellsCaijun Wu, Xiaobin Tan, Xiaoling Hu, et al.
Biophysical Journal|February 12, 2022
Immobile ligands enhance FcγR-TLR2/1 crosstalk by promoting interface overlap of receptor clustersMiao Li, Seonik Lee, Maryam Zahedian, et al.
European Journal of Immunology|July 1, 2006
Toll-like receptor engagement stimulates anti-snRNP autoreactive B cells for activationChuanlin Ding, Li Wang, Hayma Al-Ghawi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2019
Tumor Microenvironment Modulates Immunological Outcomes of Myeloid Cells with mTORC1 DisruptionChuanlin Ding, Xiaomin Sun, Caijun Wu, et al.
Pageof 5